Probiotix Health (AQSE:PBX) Debt-to-Revenue : 0.00 (As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Probiotix Health Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Probiotix Health's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was £0.00 Mil. Probiotix Health's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was £0.00 Mil. Probiotix Health's annualized Revenue for the quarter that ended in Jun. 2023 was £1.10 Mil. Probiotix Health's annualized Debt-to-Revenue for the quarter that ended in Jun. 2023 was 0.00.

Probiotix Health Debt-to-Revenue Historical Data

The historical data trend for Probiotix Health's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Probiotix Health Debt-to-Revenue Chart

Probiotix Health Annual Data

Trend

Dec18

Dec19

Dec20

Dec22

Debt-to-Revenue

N/A

2.42

1.24

N/A

Probiotix Health Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Jun22	Dec22	Jun23
Debt-to-Revenue	Get a 7-Day Free Trial			1.07	-	-	N/A	-

Competitive Comparison of Probiotix Health's Debt-to-Revenue

For the Biotechnology subindustry, Probiotix Health's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Probiotix Health's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Probiotix Health's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Probiotix Health's Debt-to-Revenue falls into.

Probiotix Health Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Probiotix Health's Debt-to-Revenue for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0	+	0)	/	N/A
	=	N/A

Probiotix Health's annualized Debt-to-Revenue for the quarter that ended in Jun. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0	+	0)	/	1.104
	=	0.00

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Jun. 2023) Revenue data.

Probiotix Health Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Probiotix Health's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Probiotix Health (AQSE:PBX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Probiotix Health PLC (AQSE:PBX) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

X90:Germany

Address

Nostell Business Estate, First Floor Zucchi Suite, Wakefield, GBR, WF4 1AB

Website

https://www.probiotixhealth-ir.com

Probiotix Health PLC develops probiotics to tackle cardiovascular disease and other lifestyle conditions which are affecting growing numbers of people across the world. The Company has one class of business, in three geographical areas being that of identifying and developing microbial strains, compounds and formulations for use in the nutraceutical industry.

Probiotix Health (AQSE:PBX) Headlines

No Headlines